down arrow

Kilitch Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE729D01010
  • NSEID: KILITCH
  • BSEID: 524500
INR
331.50
-13.5 (-3.91%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.68 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

330.35341.00

52 Week

271.30404.90
Valuation
Technical
Day's Volume

CASH

1.68 k (-88.36%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

69.23%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROE of 5.61%

  • The company has been able to generate a Return on Equity (avg) of 5.61% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Mildly Bearish range

3

With ROE of 8.7, it has a Expensive valuation with a 2.9 Price to Book Value

4

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 547 Cr (Micro Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

8.69%

stock-summary
Price to Book

2.93

Revenue and Profits (1 Year):
Net Sales:
56 Cr
(Quarterly Results - Dec 2024)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-0.75%
0%
-0.75%
1 Year
-9.41%
0%
-9.41%
2 Years
104.13%
0%
104.13%
3 Years
61.83%
0%
61.83%
4 Years
182.25%
0%
182.25%
5 Years
200.95%
0%
200.95%

Latest dividend: 0.5 per share ex-dividend date: Sep-20-2019

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
24.42%
EBIT Growth (5y)
43.05%
EBIT to Interest (avg)
2.98
Debt to EBITDA (avg)
3.98
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.64
Tax Ratio
29.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
7.41%
ROE (avg)
5.61%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
33
Price to Book Value
2.93
EV to EBIT
25.94
EV to EBITDA
22.42
EV to Capital Employed
3.24
EV to Sales
2.90
PEG Ratio
0.84
Dividend Yield
NA
ROCE (Latest)
8.53%
ROE (Latest)
8.69%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.0%)

Promoter with highest holding

Kilitch Company (pharma) Limited (41.22%)

Highest Public shareholder

Dipak Kanayalal Shah (3.11%)

Individual Investors Holdings

25.74%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 18.33% vs 41.91% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -30.86% vs 543.28% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "56.17",
          "val2": "47.47",
          "chgp": "18.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.74",
          "val2": "6.09",
          "chgp": "43.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.31",
          "chgp": "351.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.96",
          "val2": "8.62",
          "chgp": "-30.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.56%",
          "val2": "12.83%",
          "chgp": "2.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.08% vs 21.22% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 22.96% vs 79.60% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.93",
          "val2": "77.76",
          "chgp": "4.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.76",
          "val2": "14.80",
          "chgp": "-47.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.04",
          "val2": "3.01",
          "chgp": "-32.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.96",
          "val2": "8.10",
          "chgp": "22.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.59%",
          "val2": "19.03%",
          "chgp": "-9.44%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 25.15% vs 16.39% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 44.60% vs 60.03% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "137.10",
          "val2": "109.55",
          "chgp": "25.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.50",
          "val2": "17.07",
          "chgp": "-3.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.44",
          "val2": "4.61",
          "chgp": "-25.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.92",
          "val2": "11.01",
          "chgp": "44.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.04%",
          "val2": "15.58%",
          "chgp": "-3.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.58% vs 22.21% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 39.71% vs 41.79% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "154.37",
          "val2": "139.60",
          "chgp": "10.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.15",
          "val2": "17.57",
          "chgp": "37.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.93",
          "val2": "4.92",
          "chgp": "20.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.60",
          "val2": "10.45",
          "chgp": "39.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.64%",
          "val2": "12.59%",
          "chgp": "3.05%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
56.17
47.47
18.33%
Operating Profit (PBDIT) excl Other Income
8.74
6.09
43.51%
Interest
1.40
0.31
351.61%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.96
8.62
-30.86%
Operating Profit Margin (Excl OI)
15.56%
12.83%
2.73%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 18.33% vs 41.91% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -30.86% vs 543.28% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
80.93
77.76
4.08%
Operating Profit (PBDIT) excl Other Income
7.76
14.80
-47.57%
Interest
2.04
3.01
-32.23%
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.96
8.10
22.96%
Operating Profit Margin (Excl OI)
9.59%
19.03%
-9.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.08% vs 21.22% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 22.96% vs 79.60% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
137.10
109.55
25.15%
Operating Profit (PBDIT) excl Other Income
16.50
17.07
-3.34%
Interest
3.44
4.61
-25.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
15.92
11.01
44.60%
Operating Profit Margin (Excl OI)
12.04%
15.58%
-3.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 25.15% vs 16.39% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 44.60% vs 60.03% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
154.37
139.60
10.58%
Operating Profit (PBDIT) excl Other Income
24.15
17.57
37.45%
Interest
5.93
4.92
20.53%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.60
10.45
39.71%
Operating Profit Margin (Excl OI)
15.64%
12.59%
3.05%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.58% vs 22.21% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 39.71% vs 41.79% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kilitch Drugs (India) Ltd stock-summary
stock-summary
Kilitch Drugs (India) Ltd
Micro Cap
Pharmaceuticals & Drugs
Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe.
Company Coordinates stock-summary
Company Details
C-301/2 MIDC TTC Indl Area, Pawane Village Thane Maharashtra : 400705
stock-summary
Tel: 91-022-27670322/27680913/65144185
stock-summary
http://www.kilitch.in
stock-summary
info@kilitch.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."